Role of Spm-Cer-S1P signalling pathway in MMP-2 mediated U46619-induced proliferation of pulmonary artery smooth muscle cells: Protective role of epigallocatechin-3-gallate

Cell Biochemistry and Function

Volumn 33, Issue 7, 2015, Pages 463-477

  Chowdhury, Animesh ^a   Sarkar, Jaganmay ^a   Chakraborti, Tapati ^a   Chakraborti, Sajal ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

BPASMC; Cell proliferation; EGCG; proMMP 2; TxA2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3,3' (1,4 PHENYLENE)BIS[N [4 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)PHENYL]ACRYLAMIDE]; BETA ACTIN; CERAMIDE; DNA; EPIGALLOCATECHIN GALLATE; GELATINASE A; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; ILOMASTAT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; THROMBOXANE A2; TRANSCRIPTION FACTOR RELA; CARDIOVASCULAR AGENT; CATECHIN; MATRIX METALLOPROTEINASE INHIBITOR; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL LEVEL; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION (PARAMETERS); DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE SILENCING; GENE TRANSLOCATION; GENETIC TRANSFECTION; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY MUSCLE; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; BOVINE; CARDIOVASCULAR DISEASES; CELL CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; METABOLISM; PULMONARY ARTERY; SMOOTH MUSCLE CELL;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CATECHIN; CATTLE; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE INHIBITORS; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; VASOCONSTRICTOR AGENTS;

EID: 84945316703     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3136     Document Type: Article

References (37)

1. Mandegar M, Fung YCB, Huang W, Remillard CV, Rubin LJ, Yuan JXJ. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res 2004; 68: 75-103.
2. Pidgeon GP, Tamosiuniene R, Chen Get al. Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2. Circulation 2004; 110: 2701-2707.
3. 2 biosynthesis in human disease. Fed Proc 1987; 46: 154-158.
4. Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327: 70-75.
5. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. European Respiratory J 2003; 21: 892-905.
6. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003; 253: 269-285.
7. Chelladurai P, Seeger W, Pullamsetti SS. Matrix metalloproteinases and their inhibitors in pulmonary hypertension. Eur Respir J 2012; 40: 766-782.
8. Lepetit H, Eddahibi S, Fadel E, et al. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J 2005; 25: 834-842.
9. Newby AC. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 2006; 69: 614-624.
10. Wilson JL, Yu J, Taylor L, Polgar P. Hyperplastic growth of pulmonary artery smooth muscle cells from subjects with pulmonary arterial hypertension is activated through JNK and p38 MAPK. PLoS One 2015; 10: e0123662.
11. Zou T, Yang W, Hou Z, Yang J. Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox. Acta Biochim Biophys Sin 2010; 42: 908-915.
12. Hosokawa S, Haraguchi G, Sasaki A, et al. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354. Cardiovasc Res 2013; 99: 35-43.
13. 38MAPK-NFκB-MT1MMP signaling pathway in pulmonary artery smooth muscle cells. Mol Cell Biochem 2014; 385: 53-68.
14. Ibe BO, Abdallah MF, Portugal AM, Raj JU. Platelet-activating factor stimulates ovine foetal pulmonary vascular smooth muscle cell proliferation: role of nuclear factor-kappa B and cyclin-dependent kinases. Cell Prolif 2008; 41: 208-229.
15. Augé N, Maupas-Schwalm F, Elbaz M, et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 2004; 110: 571-578.
16. Maupas-Schwalm F, Augé N, Robinet C, et al. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. FASEB J 2004; 18: 1398-1400.
17. Chen J, Tang H, Sysol JR, et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. Am J Respir Crit Care Med 2014. doi:10.1164/rccm.201401-0121OC.
18. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 2007; 26: 373-388.
19. Dona M, Dell'Aica I, Calabrese F, et al. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 2003; 170: 4335-4341.
20. Das S, Mandal M, Chakraborti T, Mandal A, Chakraborti S. Isolation of MMP-2 from MMP-2/TIMP-2 complex: characterization of the complex and the free enzyme in pulmonary vascular smooth muscle plasma membrane. Biochim Biophys Acta 2004; 1674: 158-174.
21. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76: 4350-4354.
22. You R, Zheng M, McKeown-Longo PJ. The first type III repeat in fibronectin activates an inflammatory pathway in dermal fibroblasts. J Biol Chem 2010; 285: 36255-36259.
23. Lenardo MJ, Kuang A, Gifford A, Baltimore D. NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity. Proc Natl Acad Sci U S A 1988; 85: 8825-8829.
24. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
25. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-1436.
26. Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004; 43: 25-32.
27. Humbert M, Morrell NW, Archer SL, et al. J Am Coll Cardiol 2004; 43: 13-24.
28. Risinger GM, Jr, Hunt TS, Updike DL, Bullen EC, Howard EW. Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. J Biol Chem 2006; 281: 25915-25925.
29. Hwang KC, Lee KH, Jang Y, Yun YP, Chung KH. Epigallocatechin-3-gallate inhibits basic fibroblast growth factorinduced intracellular signaling transduction pathway in rat aortic smooth muscle cells. J Cardiovasc Pharmacol 2002; 39: 271-277.
30. Sachinidis A, Skach RA, Seul C, et al. Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. Faseb J 2002; 16: 893-895.
31. Weber AA, Neuhaus T, Skach RA, et al. Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. FASEB J 2004; 18: 128-130.
32. Deng YT, Lin JK. EGCG inhibits the invasion of highly invasive CL1-5 lung cancer cells through suppressing MMP-2 expression via JNK signaling and induces G2/M arrest. J Agric Food Chem 2011; 59: 13318-13327.
33. Won SM, Park YH, Kim HJ, Park KM, Lee WJ. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Exp Mol Med 2006; 38: 525-534.
34. Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R, Negre-Salvayre A. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler Thromb Vasc Biol 2002; 22: 1990-1995.
35. Eddahibi S, Morrell N, d'Ortho MP, Naeije R, Adnot S. Pathobiology of pulmonary arterial hypertension. Eur Respir J 2002; 20: 1559-1572.
36. Frisdal E, Gest V, Vieillard-Baron A, et al. Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J 2001; 18: 838-884.
37. Tan X, Chai J, Bi SC, Li JJ, Li WW, Zhou JY. Involvement of matrix metalloproteinase-2 in medial hypertrophy of pulmonary arterioles in broiler chickens with pulmonary arterial hypertension. Vet J 2012; 193: 420-425.